Yu Waye Chu Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Yu Waye Chu is Chief Medical Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 135,725 shares of CTMX, which is worth approximately $465,536. The most recent transaction as insider was on Mar 18, 2025, when has been sold 4,025 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $2,415. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
0% 3M change
417.05% 12M change
Total Value Held $465,536

Yu-Waye Chu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2025
SELL
Open market or private sale
$2,415 $0.6 p/Share
4,025 Reduced 2.88%
135,725 Common Stock
Feb 04 2025
BUY
Grant, award, or other acquisition
-
113,500 Added 44.82%
139,750 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
26,250 Added 50.0%
26,250 Common Stock

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
Chief Medical Officer
YC

Yu Waye Chu

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX